Cisplatin-Induced Hearing Loss Up for Young Children With Cancer
Cumulative incidence highest in patients aged 5 years and younger; factors that influence development include cumulative dose of cisplatin
Otic Disorders
Osteoporosis, Low Bone Density May Contribute to Hearing Loss
Magnitude of elevated risk similar among women who did and did not use bisphosphonates
Tympanostomy-Tube Placement No Better for Recurrent Otitis Media
Rate of episodes of acute otitis media not significantly lower with tympanostomy-tube placement versus medical management
USPSTF: Evidence Lacking for Screening Seniors for Hearing Loss
Current evidence insufficient for assessing balance of benefits and harms of screening for asymptomatic older adults
FDA Clears Automated Ear Cleaning Device for Earwax Removal
OtoSet is an automated ear cleaning device that resembles a set of headphones.
Generic Version of Ciprodex Otic Suspension Now Available
The otic suspension is a combination of ciprofloxacin, a fluoroquinolone antibacterial and dexamethasone, a corticosteroid.
Ear Precipitate Formation Following Otitis Externa Treatment
Upon examination, the patient’s external ear canal was found to be inflamed, red, and swollen, and she was subsequently diagnosed with otitis externa.
Pedmark Receives Priority Review for Prevention of Cisplatin-Induced Ototoxicity
The application is supported by data from 2 pivotal open-label, randomized phase 3 trials (SIOPEL 6 and ACCL0431), which compared the efficacy of sodium thiosulfate plus cisplatin to cisplatin alone for the prevention of cisplatin-induced hearing loss.
FDA Clears TOMi Scope for Noninvasive Imaging of Middle Ear
The Food and Drug Administration has granted 510(k) clearance to TOMi Scope (PhotoniCare) as an imaging tool for visualization of the human tympanic membrane and middle ear space.
